Clinical Trial Update: Effect of G17DT in Patients With Stage II/III Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating G17DT in stage II/III colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• G17DT

Snippet

Sponsor: Cancer Advances Inc. | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED